Literature DB >> 22791240

Modifiable comorbidities and disability in multiple sclerosis.

Shannon Overs1, Christina M Hughes, Jodie K Haselkorn, Aaron P Turner.   

Abstract

Multiple sclerosis is a common neurological disease that results in disability in early adulthood that may progress through a relatively normal lifespan. Other comorbid health conditions can increase the likelihood of progression of MS and independently contribute to limitations in activities and social participation. We examine common modifiable health conditions and behaviors, including hypertension, obesity, diabetes mellitus, alcohol, and smoking to determine their impacts on MS and disability. Appropriate identification and treatment can improve health status, diminish disability, and improve quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22791240     DOI: 10.1007/s11910-012-0293-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  80 in total

Review 1.  The role of patient care teams in chronic disease management.

Authors:  E H Wagner
Journal:  BMJ       Date:  2000-02-26

2.  Neuropsychological profile of acute alcohol intoxication during ascending and descending blood alcohol concentrations.

Authors:  Tom A Schweizer; Muriel Vogel-Sprott; James Danckert; Eric A Roy; Amanda Skakum; Carole E Broderick
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

3.  Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?

Authors:  Simon J C Davies; Smita A Pandit; Adrian Feeney; Brian J Stevenson; Robert W Kerwin; David J Nutt; E Jane Marshall; Stephen Boddington; Anne Lingford-Hughes
Journal:  Alcohol Alcohol       Date:  2005-09-26       Impact factor: 2.826

4.  Lifestyle factors and multiple sclerosis: A case-control study in Belgrade.

Authors:  Tatjana Pekmezovic; Jelena Drulovic; Marija Milenkovic; Mirjana Jarebinski; Nebojsa Stojsavljevic; Sarlota Mesaros; Darija Kisic; Jelena Kostic
Journal:  Neuroepidemiology       Date:  2006-11-07       Impact factor: 3.282

5.  How many people in the world have multiple sclerosis?

Authors:  G Dean
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

Review 6.  Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance.

Authors:  Paul Aveyard; Rachna Begh; Amanda Parsons; Robert West
Journal:  Addiction       Date:  2012-02-28       Impact factor: 6.526

7.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

Review 8.  Epidemiology of multiple sclerosis.

Authors:  B G Weinshenker
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

9.  Alcohol and drug abuse among persons with multiple sclerosis.

Authors:  C H Bombardier; K D Blake; D M Ehde; L E Gibbons; D Moore; G H Kraft
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

10.  Oral contraceptives and reproductive factors in multiple sclerosis incidence.

Authors:  L Villard-Mackintosh; M P Vessey
Journal:  Contraception       Date:  1993-02       Impact factor: 3.375

View more
  4 in total

1.  Association between Smoking and Health Outcomes in Postmenopausal Women Living with Multiple Sclerosis.

Authors:  Rachel Jawahar; Unsong Oh; Charles Eaton; Nicole Wright; Hilary Tindle; Kate L Lapane
Journal:  Mult Scler Int       Date:  2014-04-22

Review 2.  Multiple Sclerosis and Obesity: Possible Roles of Adipokines.

Authors:  José de Jesús Guerrero-García; Lucrecia Carrera-Quintanar; Rocío Ivette López-Roa; Ana Laura Márquez-Aguirre; Argelia Esperanza Rojas-Mayorquín; Daniel Ortuño-Sahagún
Journal:  Mediators Inflamm       Date:  2016-09-18       Impact factor: 4.711

3.  Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study.

Authors:  Kelsi A Smith; Sarah Burkill; Ayako Hiyoshi; Tomas Olsson; Shahram Bahmanyar; David Wormser; Yvonne Geissbühler; Alan Moore; Vineetkumar Kharat; Scott Montgomery
Journal:  Mult Scler       Date:  2020-03-12       Impact factor: 6.312

4.  Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Jan Kocica; Jan Kolcava; Michaela Sladeckova; Pavel Stourac; Eva Vlckova; Filip Dosbaba; Jitka Kratochvilova; Josef Bednarik
Journal:  J Rehabil Med       Date:  2022-03-29       Impact factor: 2.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.